胃蛋白酶在特发性声门下狭窄上皮-间质转化中的作用
本研究为体外转化研究,在人喉上皮细胞中观察胃蛋白酶对上皮-间质转化(EMT)标志物的影响,并以人声带成纤维细胞进行划痕迁移实验。结果显示胃蛋白酶单独或联合弱酸对MMP1、MMP9、FN1、COL1A1、HAS2、CDH1基因表达及MMP-9、纤连蛋白蛋白表达均无影响,对成纤维细胞迁移也无影响。作者认为该体外急性暴露研究未提供胃蛋白酶直接导致声门下上皮细胞纤维化的因果证据。
要点
- 胃蛋白酶对喉上皮细胞EMT相关基因和蛋白表达无影响。
- 胃蛋白酶联合弱酸对EMT标志物表达也无影响。
- 胃蛋白酶和/或酸对成纤维细胞迁移无影响。
核心结论
- 尽管胃蛋白酶存在于特发性声门下狭窄患者声门下黏膜,该体外急性暴露研究未提供其直接导致声门下上皮细胞培养中纤维化发生的因果证据。
研究设计与样本
- 体外转化研究,使用人喉上皮细胞培养和人永生化声带成纤维细胞。
主要发现
- 胃蛋白酶(0.1 mg/mL或1.0 mg/mL,pH7,24和48小时)对MMP1、MMP9、FN1、COL1A1、HAS2、CDH1基因表达及MMP-9、纤连蛋白蛋白表达无影响。
- 弱酸条件下(pH5±0.1 mg/mL胃蛋白酶10分钟)胃蛋白酶对上述EMT标志物表达也无影响。
- 胃蛋白酶和/或酸对成纤维细胞迁移无影响(划痕实验:pH5±0.1 mg/mL胃蛋白酶预处理10分钟,或pH7±0.1至1 mg/mL胃蛋白酶持续处理24小时)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Idiopathic subglottic stenosis (iSGS) is commonly characterized by laryngeal fibrosis thought to arise by epithelia-mesenchymal transition (EMT) induced by chronic inflammation. Pepsin is a potent inducer of inflammation in the airways during chronic laryngopharyngeal reflux and has been observed in the subglottic mucosa of patients with iSGS, absent in normal mucosa. The aim of this study was to examine the effect of pepsin on mechanisms of EMT in laryngeal cells with implications for iSGS. STUDY DESIGN: In vitro translational research study. METHODS: Human laryngeal epithelial cell cultures were exposed to 0.1 mg/mL or 1.0 mg/mL pepsin at pH7 for 24 and 48 hours, or media pH5 ± 0.1 mg/mL pepsin for 10 minutes and harvested after 24 and 48 hours. EMT marker expression was measured by qPCR and enzyme-linked immunosorbent assays. Wound-healing scratch assay was performed on immortalized human vocal fold fibroblasts pretreated with media pH5 ± 0.1 mg/mL pepsin (10 minutes) or continuously treated with media pH7 ± 0.1 to 1 mg/mL pepsin for 24 hours. RESULTS: Pepsin yielded no effect on MMP1, MMP9, FN1, COL1A1, HAS2, or CDH1 gene expression or matrix metalloproteinase-9 or fibronectin protein expression, either alone or in the presence of weak acid. Pepsin and/or acid produced no effect on fibroblast migration. CONCLUSION: Whereas pepsin has been shown to be present in the subglottic mucosa of patients with iSGS, this in vitro acute exposure investigation does not provide evidence of a direct causal role for development of fibrosis in subglottic epithelial cell cultures. LEVELS OF EVIDENCE: NA. Laryngoscope, 130:154-158, 2020.
引用
- McCann AJ, Samuels TL, Blumin JH, et al. The role of pepsin in epithelia-mesenchymal transition in idiopathic subglottic stenosis. Laryngoscope. 2019. PMID: 30776094. doi:10.1002/lary.27879
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。